G-N (drug)
Pharmaceutical compound
From Wikipedia, the free encyclopedia
G-N, also known as 1,4-dimethoxynaphthyl-2-isopropylamine, is a chemical compound of the phenethylamine, amphetamine, DOx, and naphthylethylamine families.[1][2] It is one of several homologues of Ganesha (G).[1][2]
- None
| Clinical data | |
|---|---|
| Other names | GN; Ganesha-N; GANESHA-N; 3C-G-N; 1,4-Dimethoxynaphthyl-2-isopropylamine; DOG-N |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C15H19NO2 |
| Molar mass | 245.322 g·molâ1 |
| 3D model (JSmol) | |
| |
| |
In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists G-N's dose as unknown and its duration as unknown.[1][2] He described trying the compound at an initial dose of 2 mg orally, which produced no effects, but did not complete its evaluation or try higher doses.[1][2]
The chemical synthesis of G-N has been described.[1]
G-N was first described in the literature by Shulgin in PiHKAL in 1991.[1] It is a controlled substance in Canada under phenethylamine blanket-ban language.[3]
See also
- Ganesha (psychedelics)
- DOx (psychedelics)
- 2C-G-N
- Naphthylaminopropane (NAP; PAL-287)